Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.2K Buy
+430
New +$17K ﹤0.01% 4774
2021
Q4
– Sell
-200
Closed -$4K – 4460
2021
Q3
$4K Hold
200
– – ﹤0.01% 4623
2021
Q2
$3K Hold
200
– – ﹤0.01% 4778
2021
Q1
$3K Buy
+200
New +$3.42K ﹤0.01% 4526
2015
Q4
– Sell
-3,920
Closed -$50K – 6266
2015
Q3
$50K Sell
3,920
-2,020
-34% -$28K ﹤0.01% 5017
2015
Q2
$88K Sell
5,940
-425
-7% -$6.58K ﹤0.01% 4754
2015
Q1
$91K Sell
6,365
-80,350
-93% -$1.05M ﹤0.01% 4911
2014
Q4
$1.08M Buy
86,715
+76,355
+737% +$999K ﹤0.01% 3149
2014
Q3
$143K Buy
10,360
+9,625
+1,310% +$148K ﹤0.01% 5042
2014
Q2
$13K Sell
735
-465
-39% -$7.08K ﹤0.01% 6703
2014
Q1
$16K Buy
+1,200
New +$18.4K ﹤0.01% 6707

Other funds holding IX

Barclays's IX Position: Q3 2026 in Review

Barclays opened a new position in ORIX (IX) in Q3 2026: 430 shares worth $16.2K. The stake represents ﹤0.01% of the portfolio and ranks #4774 among its holdings. This is a return to the name: Barclays previously reported a position in IX as recently as Q3 2021.

Barclays first reported a position in IX in Q1 2014 and has held it in 11 quarters since. The position peaked at $1.08M in Q4 2014. 171 funds tracked by Wall St. Rank hold IX as of Q3 2026.

  • Barclays held 430 shares of ORIX worth $16.2K as of Q3 2026.
  • ORIX was a new Barclays position in Q3 2026.
  • ORIX made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4774 holding.
  • Barclays first reported a position in ORIX in Q1 2014 and has held it in 11 quarters since.
  • Barclays's ORIX position peaked at $1.08M in Q4 2014.
  • 171 funds tracked by Wall St. Rank held ORIX as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.